...
首页> 外文期刊>European Journal of Lipid Science and Technology >Preparation and evaluation of a novel sunflower oil-based waterborne polyurethane nanoparticles for sustained delivery of hydrophobic drug
【24h】

Preparation and evaluation of a novel sunflower oil-based waterborne polyurethane nanoparticles for sustained delivery of hydrophobic drug

机译:新型葵花籽油的水性聚氨酯纳米粒子的制备与评价疏水药物持续递送

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In the present study, a nanoparticulate system based on bio-based waterborne polyurethane for the controlled delivery of raloxifene-hydrochloride, as a model and drug with poor bioavailability, is described and considered to be an antiproliferative agent of mammary tissue. The main goal of this study was to investigate the effect of the encapsulation of raloxifene in bio-based polyurethane, synthesized for the first time, as a polymer with anionic surface on the release profile as well as antiproliferative activity. Polyurethane was synthesized from bio-based polyol, which was derived from sunflower oil. The structure of bio-based polyurethane was characterized using (HNMR)-H-1, FT-IR, and TGA. Drug release studies showed controlled release of raloxifene from anionic nanoparticles that was mainly driven by diffusion-based mechanism. Degradation of nanoparticles during the release of Ral was investigated applying SEM and caused mainly through the hydrolysis of polyurethane. MCF-7 cell viability studies demonstrated that, raloxifene loaded nanoparticles promote the antiproliferative activity after 72h of treatment. The bio-based polyurethane has potential as a useful carrier for controlled release of hydrophobic drugs. Practical applications: A novel carboxylic acid group containing polyol was prepared from sunflower oil and used in preparation of biodegradable waterborne polyurethane. The synthesized waterborne polyurethane was loaded by drug and its loading capacity was studied. Drug release studies showed controlled release of raloxifene from anionic nanoparticles that was mainly driven by diffusion-based mechanism. Cell viability studies demonstrated that raloxifene loaded nanoparticles promote the antiproliferative activity.
机译:在本研究中,描述了基于生物基水性聚氨酯的纳米颗粒系统,用于控制盐酸雷洛昔芬 - 盐酸盐的控制递送,作为具有较差的生物利用度的模型和药物,是乳腺组织的抗增殖剂。本研究的主要目的是探讨Raloxifene在生物基聚氨酯中封装的影响,首次合成,作为释放曲线和抗增殖活性的阴离子表面的聚合物。聚氨酯由生物基多醇合成,该多元醇来自葵花籽油。使用(HNMR)-H-1,FT-IR和TGA表征生物基聚氨酯的结构。药物释放研究显示来自主要由基于扩散机制驱动的阴离子纳米颗粒的raloxifene控制释放。研究了纳米颗粒在RAL释放期间的降解施用SEM,主要通过聚氨酯的水解引起。 MCF-7细胞活力研究证明,雷洛昔芬负载纳米颗粒在72H处理后促进抗增殖活性。生物基聚氨酯具有潜力作为控制疏水药物的可控制释放的有用载体。实际应用:由葵花籽油制备含有多元醇的新型羧酸基团,用于制备可生物降解的水性聚氨酯。通过药物加载合成的水性聚氨酯,并研究了其负载能力。药物释放研究显示来自主要由基于扩散机制驱动的阴离子纳米颗粒的raloxifene控制释放。细胞活力研究表明,Raloxifene负载纳米颗粒促进抗增殖活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号